Mar 7, 2018 | Behavioral, Drugs, Products, Substance Abuse
As part of an initiative to expand access to medication-assisted treatment (MAT), the FDA plans to allow drug companies to sell medications that do not completely stop addiction but rather help alleviate cravings. The agency will put forth guidance and recommendations later this month. This move to expand access reflects the ongoing support for MAT.Click to read more.
Feb 17, 2018 | Behavioral
A recent report by the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC) finds that 4% of adult Americans are diagnosed with a serious mental illness (SMI) and 7%-12% of youths with a serious emotional disturbance (SED). Effective treatments exist, yet they are seriously underutilized. Over the next five years, the ISMICC will evaluate current federal programs and implement recommendations put forth by the non-federal members of the ISMICC. Click to read more.
